AR and prostate cancer: Prostate cancer is driven by the androgen receptor (Yap et al., 2016; Dai et al., 2017), and is directly associated with nuclear steroidal AR (Bentel and Tilley, 1996; Culig et al., 2002; Gelmann, 2002).